Bone Biologics Corporation (BBLG) stock declined over -4.72%, trading at $1.21 on NASDAQ, down from the previous close of $1.27. The stock opened at $1.25, fluctuating between $1.21 and $1.25 in the recent session.
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.
Employees | 2 |
Beta | 0.74 |
Sales or Revenue | $0.00 |
5Y Sales Change% | 0% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Devices |
Bone Biologics Corporation (NASDAQ: BBLG) stock price is $1.21 in the last trading session. During the trading session, BBLG stock reached the peak price of $1.25 while $1.21 was the lowest point it dropped to. The percentage change in BBLG stock occurred in the recent session was -4.72% while the dollar amount for the price change in BBLG stock was -$0.06.
The NASDAQ listed BBLG is part of Medical - Devices industry that operates in the broader Healthcare sector. Bone Biologics Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Shun'ichi Kuroda
Co-Founder & Member of Scientific Advisory Board
Mr. Jeffrey Frelick
Chief Executive Officer & Pres
Ms. Deina H. Walsh
Chief Financial Officer
BBLG's closing price is 58.75% higher than its 52-week low of $0.80 where as its distance from 52-week high of $10.56 is -87.97%.
Number of BBLG employees currently stands at 2.
Official Website of BBLG is: https://www.bonebiologics.com
BBLG could be contacted at phone 781 552 4452 and can also be accessed through its website. BBLG operates from 2 Burlington Woods Drive, Burlington, MA 01803, United States.
BBLG stock volume for the day was 6.55K shares. The average number of BBLG shares traded daily for last 3 months was 3.11M.
The market value of BBLG currently stands at $2.98M with its latest stock price at $1.21 and 2.46M of its shares outstanding.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com